Pharmaceutical Sourcing and Onshoring Survey – 2022 Edition
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Recent geopolitical events are causing the pharma industry to consider its supply chain more carefully than ever. Highly developed pharma markets rely on foreign suppliers for their drugs, especially China and India. The COVID-19 pandemic, rising raw material and fuel costs, Russia’s war against Ukraine, and other events are prompting industry conversations about drug shortages and supply chain security.
The pharmaceutical sourcing and onshoring survey report assess the outlook for pharmaceutical supply chains over the next 12 months to determine to what extent bio/pharmaceutical companies and their service providers are concerned, and whether they plan to “onshore” or “offshore” their manufacturing steps.
Key Findings of Pharmaceutical Onshoring Survey
Most companies surveyed do not have onshoring plans and will maintain the same onshoring/offshoring balance. However, onshoring plans are more popular than offshoring. European companies are more likely to onshore than North American companies.
Onshoring plans are similar despite more API currently being made abroad than dosage. Client demand, cost of goods and labor, and geopolitical concerns influence API sourcing while supply chain security, client demand, and quality influence dose/packaging decisions.
Pharmaceutical Industry Value Chain
The key value chains of the pharmaceutical industry are active pharmaceutical ingredients (API), followed by dose, and packaging.
API Onshoring Plans by Geography
Three regions were considered for the API sourcing and onshoring survey. They were North America, Europe, and APAC. More than 20% of the respondents in North America were willing to shift a greater proportion of the API manufacturing to the headquarters country or main countries where the clients operate. More than 40% of the clients believed that onshoring supply chains will make them more secure.
Onshoring Plans by Drug Types
Small molecule drugs were the most popular for onshoring. US politicians have emphasized onshoring more advanced/complex molecules. Innovator drugs are more popular for onshoring in North America while generic drugs are more popular for onshoring in Europe. Orphan and COVID-19 drugs are the other popular choices for onshoring.
To know more about the pharmaceutical sourcing and onshoring survey, download a free report sample
Pharmaceutical Sourcing and Onshoring Survey Report Overview
Key Value Chains | Active Pharmaceutical Ingredient (API), Dose, and Packaging |
Key Geographical Regions | North America, Europe, and APAC |
Scope
This report provides:
- Overview of supply chain trends and key stakeholders’ attitudes to onshoring and sourcing
- Detailed survey of industry plans to change sourcing strategy
- Analysis by geography, drug molecule type, company type, and manufacturing step
Reasons to Buy
This report is required reading for:
- CMO executives who must have a deep understanding of the pharmaceutical supply chain to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Table of Contents
Figures
Frequently asked questions
-
What are the pharmaceutical industry value chains?
The key value chains of the pharmaceutical industry are active pharmaceutical ingredients (API), followed by dose, and packaging.
-
Which are the geographical regions in API onshoring plans?
The three regions considered for the API onshoring plans were North America, Europe, and APAC.
-
Which region is most likely to onshore?
European companies are more likely to onshore than North American companies.
-
What are the influences on API sourcing?
Client demand, cost of goods and labor, and geopolitical concerns influence API sourcing.
-
What are the influences on dosage sourcing?
Supply chain security, client demand, and quality influence dosage sourcing.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.